Renal Cell Carcinoma VEGF - Prognostic Factors VEGF-Targeted Therapy

Purpose: To evaluate a patient for a hepatocellular carcinoma using the up-to-seven criteria of Mazzaferro et al.

Info MyLikes MyPaths

Evaluation

Are you evaluating a patient with metastatic renal cell carcinoma treated with VEGF-targeted therapy?

Yes

Karnofsky Performance Scale (from 10 to 100)

KPS

Number of months since renal cell carcinoma first diagnosed

Hemoglobin

Lower limit of normal for hemoglobin

Serum calcium

Upper limit of the normal reference range for serum calcium

White blood cell count

Percent neutrophils in the differential count (enter from 0 to 100)

Upper limit of the normal reference range for absolute neutrophil count

Platelet count

Upper limit of the normal reference range for platelet count

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

Absolute neutrophil count

Number of risk factors

Risk group

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Risk Factors
- Clear Cell Renal Cell Carcinoma Prognostic Factors
- Chances of Aggressive Carcinoma in Renal Tumor Removed By Partial Nephrectomy
Clinical Diagnosis, Including Family History For Genetics
- Aggressive Phenotypic Features for Chromophobe Renal Cell Carcinoma
- Diagnostic Features of a Chromophobe Renal Cell Carcinoma
Severity, Prognosis, Stage

Monitoring

Response To Therapy
- Prediction Model of Leibovich et al for Patients with Clear Cell Renal Cell Carcinoma After Radical Nephrectomy
- The Stage, Size, Grade and Necrosis (SSIGN) Score of Frank et al for Predicting Survival in a Patient with a Clear Cell Renal Cell Carcinoma
Disease Progression
- Chances of Aggressive Carcinoma in Renal Tumor Removed By Partial Nephrectomy

Specialty

Hematology Oncology

Objective

severity
prognosis
stage

ICD-10

C64 - Malignant neoplasm of kidney, except renal pelvis

Info

Purpose: To evaluate a patient for a hepatocellular carcinoma using the up-to-seven criteria of Mazzaferro et al.

Specialty: Hematology Oncology

Objective: severity, prognosis, stage

ICD-10: C64,

Save Data

Identifier

Enter 1 to 5 characters as ID

Email

Your registered email

Other

Email to

Please separate multiple email IDs with comma (,)

Consult Report

Identifier

Enter 1 to 5 characters as ID

Add to MyPath

Select path

New path